Tinnitus Patient Preferences Survey

Part of paid clinical trials in New York, New York.

Sponsor
Nicolas Gninenko
Study ID
NCT06782308
Status
Recruiting
Apply to this trial

Conditions

  • Tinnitus, Bilateral
  • Tinnitus, Hearing Loss, Cochlear Implant Users
  • Tinnitus, Noise Induced
  • Tinnitus, Subjective

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Survey using a questionnaire. — OTHER
    patients preferences survey

Study Details

The goal of this survey is to assess several aspects related to patient preferences regarding interventions for alleviating tinnitus through invasive electrical brain stimulation (neuromodulation). This survey covers the acceptance of a surgically-placed brain implant, of its associated risks related to the neurosurgical procedure, usability considerations, and the willingness/ability to pay for such a treatment. Neurosoft Bioelectronics will use the collected patients' feedback and usability preferences data for the development of a novel minimally invasive brain implant aimed at alleviating tinnitus.

Key Dates

Start date
Jan 13, 2025
Status verified
Apr 2026
Primary completion
Oct 30, 2026
Completion
Dec 30, 2026

Study Design

Enrollment
500 participants (estimated)

Arms

  • Arm: patients with tinnitus

Primary Outcome Measure

Acceptance of invasive neuromodulation treatments for chronic tinnitus [ Time Frame: 1 year ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Neurosoft Bielectronics US Inc.New YorkNew York10016
Nicolas Gninenko, PhD
[email protected]
000-000-0000
Nicolas Gninenko, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in New York, NY

By research site
Neurosoft Bielectronics US Inc.· New York, NY

Related Studies